Governor Hochul Announces Applications Open for Second Round of New York’s $40 Million Biodefense Commercialization Fund (Applications and Fund Guidelines Available Here)
Academic teams developing promising diagnostics, vaccines, therapeutics, digital epidemiology, pathogen surveillance tools and other innovations to prevent, treat or mitigate serious infectious disease threats can apply for grants of up to $500,000 to help fast track advanced intellectual property. An emphasis will be placed on supporting the development of innovations with the highest potential for commercial viability.
The Fund, which awarded $15.3 Million in grants to eight startups and 10 academic centers in April, was established to accelerate the development and commercialization of life science research innovations that address serious infectious disease health threats while creating jobs and encouraging continued growth across New York State's expanding life science industry.
The deadline to apply is Thursday, October 6, 2022 at 5 p.m. EDT. More information can be found online here.